What does a computed tomography (CT) urogram evaluate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What Does CT Urogram Check For?

CT urography (CTU) is a comprehensive imaging examination specifically designed to evaluate the entire urinary tract—including the kidneys, renal collecting systems, ureters, and bladder—primarily to detect urothelial malignancies, kidney stones, masses, and other urinary tract pathology. 1

Primary Clinical Indications

CTU serves as the preferred imaging modality for several key clinical scenarios:

Hematuria Evaluation

  • CTU is the gold standard for evaluating gross hematuria and high-risk microhematuria, replacing older techniques like intravenous urography 1, 2
  • Detects urothelial cell carcinoma with 96% sensitivity and 99% specificity 3
  • Identifies renal cell carcinoma, bladder cancer, and upper urinary tract malignancies
  • Evaluates urinary stones, which are the most common cause of hematuria 4

Urothelial Cancer Detection and Staging

  • CTU is the most accurate modality for diagnosing and staging urothelial malignancies, both locally and for distant metastases 3
  • Demonstrates 91% diagnostic accuracy in detecting urothelial cancers 3
  • Essential for detecting synchronous tumors (multifocal disease occurs in 25-30% of upper tract urothelial cancers) 3
  • Can identify spiculated margins and tissue invasion patterns that predict higher tumor stages 3

Technical Components

CTU is distinguished from standard CT abdomen/pelvis by its specialized protocol 1:

  • Unenhanced phase: Evaluates kidney size, shape, position, and detects calculi without contrast interference 4
  • Nephrographic phase (post-IV contrast): Optimal for visualizing renal parenchymal masses and assessing kidney enhancement 1, 4
  • Excretory phase (≥5 minutes post-contrast): Evaluates the collecting systems, ureters, and bladder for urothelial abnormalities 1, 4
  • Thin-slice acquisition with multiplanar reconstructions (maximum intensity projection, 3D volume rendering) 1

Specific Pathologies Detected

CTU comprehensively identifies:

  • Malignancies: Urothelial carcinoma, renal cell carcinoma, bladder cancer
  • Urolithiasis: Superior to all other modalities for stone detection and characterization 5
  • Obstructive uropathy: Hydronephrosis, ureteral strictures (higher hydronephrosis grades predict advanced tumor stages) 3
  • Trauma: Urinary tract injuries
  • Infections: Pyelonephritis, abscess formation
  • Vascular abnormalities: Though not the primary indication 4
  • Congenital anomalies: Anatomic variants of the urinary tract

Key Advantages Over Alternative Imaging

CTU surpasses intravenous urography and other traditional methods because it 5:

  • Visualizes small masses obscured by contrast or bowel gas on conventional urography
  • Distinguishes enhancing tumors from non-enhancing blood clots or stones 3
  • Evaluates non-functioning/obstructed kidneys that don't excrete contrast 3
  • Provides cross-sectional imaging of surrounding abdominal organs 1

Important Clinical Caveats

  • CTU may miss very small or flat urothelial lesions that require direct visualization with cystoscopy 3
  • Cannot reliably distinguish between muscle-invasive (≥T2) and non-invasive (≤T1) tumors based on CT values alone 3
  • Microscopic tumor invasion into surrounding tissue remains challenging to identify 3
  • Patients with identified benign causes of microhematuria (vigorous exercise, infection, menstruation, recent procedures) do not benefit from CTU 1

The examination provides a single, comprehensive evaluation replacing multiple historical tests, making it the current standard for urinary tract imaging in appropriate clinical contexts 4, 2.

References

Guideline

acr appropriateness criteria® hematuria.

Journal of the American College of Radiology, 2020

Research

CT urography for hematuria.

Nature reviews. Urology, 2012

Guideline

acr appropriateness criteria® pretreatment staging of urothelial cancer: 2024 update.

Journal of the American College of Radiology, 2024

Research

Essentials of Computed Tomography Imaging of Hematuria.

Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.